table of content
1 Introduction to Research & Analysis Reports
1.1 Antiviral Immunoglobulin Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by IgG Purity
1.2.3 Segment by Therapeutic Area
1.2.4 Segment by Application
1.3 Global Antiviral Immunoglobulin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiviral Immunoglobulin Overall Market Size
2.1 Global Antiviral Immunoglobulin Market Size: 2025 VS 2034
2.2 Global Antiviral Immunoglobulin Market Size, Prospects & Forecasts: 2021-2034
2.3 Global Antiviral Immunoglobulin Sales: 2021-2034
3 Company Landscape
3.1 Top Antiviral Immunoglobulin Players in Global Market
3.2 Top Global Antiviral Immunoglobulin Companies Ranked by Revenue
3.3 Global Antiviral Immunoglobulin Revenue by Companies
3.4 Global Antiviral Immunoglobulin Sales by Companies
3.5 Global Antiviral Immunoglobulin Price by Manufacturer (2021-2026)
3.6 Top 3 and Top 5 Antiviral Immunoglobulin Companies in Global Market, by Revenue in 2025
3.7 Global Manufacturers Antiviral Immunoglobulin Product Type
3.8 Tier 1, Tier 2, and Tier 3 Antiviral Immunoglobulin Players in Global Market
3.8.1 List of Global Tier 1 Antiviral Immunoglobulin Companies
3.8.2 List of Global Tier 2 and Tier 3 Antiviral Immunoglobulin Companies
4 Sights by Type
4.1 Overview
4.1.1 Segment by Type - Global Antiviral Immunoglobulin Market Size Markets, 2025 & 2034
4.1.2 Human Plasma Derived Polyclonal
4.1.3 Hyperimmune Specific Globulin
4.1.4 Recombinant Monoclonal Antibody (mAb)
4.1.5 Animal Derived (Equine/Ovine)
4.1.6 Others
4.2 Segment by Type - Global Antiviral Immunoglobulin Revenue & Forecasts
4.2.1 Segment by Type - Global Antiviral Immunoglobulin Revenue, 2021-2026
4.2.2 Segment by Type - Global Antiviral Immunoglobulin Revenue, 2027-2034
4.2.3 Segment by Type - Global Antiviral Immunoglobulin Revenue Market Share, 2021-2034
4.3 Segment by Type - Global Antiviral Immunoglobulin Sales & Forecasts
4.3.1 Segment by Type - Global Antiviral Immunoglobulin Sales, 2021-2026
4.3.2 Segment by Type - Global Antiviral Immunoglobulin Sales, 2027-2034
4.3.3 Segment by Type - Global Antiviral Immunoglobulin Sales Market Share, 2021-2034
4.4 Segment by Type - Global Antiviral Immunoglobulin Price (Manufacturers Selling Prices), 2021-2034
5 Sights by IgG Purity
5.1 Overview
5.1.1 Segment by IgG Purity - Global Antiviral Immunoglobulin Market Size Markets, 2025 & 2034
5.1.2 Standard Fractionated Grade (90%�95%)
5.1.3 Clinical High Purity Grade (96%�98%)
5.1.4 Ultra Purified Specialty Grade(99%)
5.2 Segment by IgG Purity - Global Antiviral Immunoglobulin Revenue & Forecasts
5.2.1 Segment by IgG Purity - Global Antiviral Immunoglobulin Revenue, 2021-2026
5.2.2 Segment by IgG Purity - Global Antiviral Immunoglobulin Revenue, 2027-2034
5.2.3 Segment by IgG Purity - Global Antiviral Immunoglobulin Revenue Market Share, 2021-2034
5.3 Segment by IgG Purity - Global Antiviral Immunoglobulin Sales & Forecasts
5.3.1 Segment by IgG Purity - Global Antiviral Immunoglobulin Sales, 2021-2026
5.3.2 Segment by IgG Purity - Global Antiviral Immunoglobulin Sales, 2027-2034
5.3.3 Segment by IgG Purity - Global Antiviral Immunoglobulin Sales Market Share, 2021-2034
5.4 Segment by IgG Purity - Global Antiviral Immunoglobulin Price (Manufacturers Selling Prices), 2021-2034
6 Sights by Therapeutic Area
6.1 Overview
6.1.1 Segment by Therapeutic Area - Global Antiviral Immunoglobulin Market Size Markets, 2025 & 2034
6.1.2 Transplantation
6.1.3 Infectious Disease Prophylaxis
6.1.4 Immunodeficiency
6.1.5 Neurology (Autoimmune)
6.1.6 Others
6.2 Segment by Therapeutic Area - Global Antiviral Immunoglobulin Revenue & Forecasts
6.2.1 Segment by Therapeutic Area - Global Antiviral Immunoglobulin Revenue, 2021-2026
6.2.2 Segment by Therapeutic Area - Global Antiviral Immunoglobulin Revenue, 2027-2034
6.2.3 Segment by Therapeutic Area - Global Antiviral Immunoglobulin Revenue Market Share, 2021-2034
6.3 Segment by Therapeutic Area - Global Antiviral Immunoglobulin Sales & Forecasts
6.3.1 Segment by Therapeutic Area - Global Antiviral Immunoglobulin Sales, 2021-2026
6.3.2 Segment by Therapeutic Area - Global Antiviral Immunoglobulin Sales, 2027-2034
6.3.3 Segment by Therapeutic Area - Global Antiviral Immunoglobulin Sales Market Share, 2021-2034
6.4 Segment by Therapeutic Area - Global Antiviral Immunoglobulin Price (Manufacturers Selling Prices), 2021-2034
7 Sights by Application
7.1 Overview
7.1.1 Segment by Application - Global Antiviral Immunoglobulin Market Size, 2025 & 2034
7.1.2 Hospitals
7.1.3 Specialty Clinics
7.1.4 Home Care
7.1.5 Others
7.2 Segment by Application - Global Antiviral Immunoglobulin Revenue & Forecasts
7.2.1 Segment by Application - Global Antiviral Immunoglobulin Revenue, 2021-2026
7.2.2 Segment by Application - Global Antiviral Immunoglobulin Revenue, 2027-2034
7.2.3 Segment by Application - Global Antiviral Immunoglobulin Revenue Market Share, 2021-2034
7.3 Segment by Application - Global Antiviral Immunoglobulin Sales & Forecasts
7.3.1 Segment by Application - Global Antiviral Immunoglobulin Sales, 2021-2026
7.3.2 Segment by Application - Global Antiviral Immunoglobulin Sales, 2027-2034
7.3.3 Segment by Application - Global Antiviral Immunoglobulin Sales Market Share, 2021-2034
7.4 Segment by Application - Global Antiviral Immunoglobulin Price (Manufacturers Selling Prices), 2021-2034
8 Sights Region
8.1 By Region - Global Antiviral Immunoglobulin Market Size, 2025 & 2034
8.2 By Region - Global Antiviral Immunoglobulin Revenue & Forecasts
8.2.1 By Region - Global Antiviral Immunoglobulin Revenue, 2021-2026
8.2.2 By Region - Global Antiviral Immunoglobulin Revenue, 2027-2034
8.2.3 By Region - Global Antiviral Immunoglobulin Revenue Market Share, 2021-2034
8.3 By Region - Global Antiviral Immunoglobulin Sales & Forecasts
8.3.1 By Region - Global Antiviral Immunoglobulin Sales, 2021-2026
8.3.2 By Region - Global Antiviral Immunoglobulin Sales, 2027-2034
8.3.3 By Region - Global Antiviral Immunoglobulin Sales Market Share, 2021-2034
8.4 North America
8.4.1 By Country - North America Antiviral Immunoglobulin Revenue, 2021-2034
8.4.2 By Country - North America Antiviral Immunoglobulin Sales, 2021-2034
8.4.3 United States Antiviral Immunoglobulin Market Size, 2021-2034
8.4.4 Canada Antiviral Immunoglobulin Market Size, 2021-2034
8.4.5 Mexico Antiviral Immunoglobulin Market Size, 2021-2034
8.5 Europe
8.5.1 By Country - Europe Antiviral Immunoglobulin Revenue, 2021-2034
8.5.2 By Country - Europe Antiviral Immunoglobulin Sales, 2021-2034
8.5.3 Germany Antiviral Immunoglobulin Market Size, 2021-2034
8.5.4 France Antiviral Immunoglobulin Market Size, 2021-2034
8.5.5 U.K. Antiviral Immunoglobulin Market Size, 2021-2034
8.5.6 Italy Antiviral Immunoglobulin Market Size, 2021-2034
8.5.7 Russia Antiviral Immunoglobulin Market Size, 2021-2034
8.5.8 Nordic Countries Antiviral Immunoglobulin Market Size, 2021-2034
8.5.9 Benelux Antiviral Immunoglobulin Market Size, 2021-2034
8.6 Asia
8.6.1 By Region - Asia Antiviral Immunoglobulin Revenue, 2021-2034
8.6.2 By Region - Asia Antiviral Immunoglobulin Sales, 2021-2034
8.6.3 China Antiviral Immunoglobulin Market Size, 2021-2034
8.6.4 Japan Antiviral Immunoglobulin Market Size, 2021-2034
8.6.5 South Korea Antiviral Immunoglobulin Market Size, 2021-2034
8.6.6 Southeast Asia Antiviral Immunoglobulin Market Size, 2021-2034
8.6.7 India Antiviral Immunoglobulin Market Size, 2021-2034
8.7 South America
8.7.1 By Country - South America Antiviral Immunoglobulin Revenue, 2021-2034
8.7.2 By Country - South America Antiviral Immunoglobulin Sales, 2021-2034
8.7.3 Brazil Antiviral Immunoglobulin Market Size, 2021-2034
8.7.4 Argentina Antiviral Immunoglobulin Market Size, 2021-2034
8.8 Middle East & Africa
8.8.1 By Country - Middle East & Africa Antiviral Immunoglobulin Revenue, 2021-2034
8.8.2 By Country - Middle East & Africa Antiviral Immunoglobulin Sales, 2021-2034
8.8.3 Turkey Antiviral Immunoglobulin Market Size, 2021-2034
8.8.4 Israel Antiviral Immunoglobulin Market Size, 2021-2034
8.8.5 Saudi Arabia Antiviral Immunoglobulin Market Size, 2021-2034
8.8.6 UAE Antiviral Immunoglobulin Market Size, 2021-2034
9 Manufacturers & Brands Profiles
9.1 ADMA Biologics (US)
9.1.1 ADMA Biologics (US) Company Summary
9.1.2 ADMA Biologics (US) Business Overview
9.1.3 ADMA Biologics (US) Antiviral Immunoglobulin Major Product Offerings
9.1.4 ADMA Biologics (US) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.1.5 ADMA Biologics (US) Key News & Latest Developments
9.2 AstraZeneca (UK/Sweden)
9.2.1 AstraZeneca (UK/Sweden) Company Summary
9.2.2 AstraZeneca (UK/Sweden) Business Overview
9.2.3 AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Major Product Offerings
9.2.4 AstraZeneca (UK/Sweden) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.2.5 AstraZeneca (UK/Sweden) Key News & Latest Developments
9.3 Bharat Serums & Vaccines (India)
9.3.1 Bharat Serums & Vaccines (India) Company Summary
9.3.2 Bharat Serums & Vaccines (India) Business Overview
9.3.3 Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Major Product Offerings
9.3.4 Bharat Serums & Vaccines (India) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.3.5 Bharat Serums & Vaccines (India) Key News & Latest Developments
9.4 Biotest (Germany)
9.4.1 Biotest (Germany) Company Summary
9.4.2 Biotest (Germany) Business Overview
9.4.3 Biotest (Germany) Antiviral Immunoglobulin Major Product Offerings
9.4.4 Biotest (Germany) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.4.5 Biotest (Germany) Key News & Latest Developments
9.5 Boya Bio (China)
9.5.1 Boya Bio (China) Company Summary
9.5.2 Boya Bio (China) Business Overview
9.5.3 Boya Bio (China) Antiviral Immunoglobulin Major Product Offerings
9.5.4 Boya Bio (China) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.5.5 Boya Bio (China) Key News & Latest Developments
9.6 China Biologic Products (CNBG) (China)
9.6.1 China Biologic Products (CNBG) (China) Company Summary
9.6.2 China Biologic Products (CNBG) (China) Business Overview
9.6.3 China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Major Product Offerings
9.6.4 China Biologic Products (CNBG) (China) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.6.5 China Biologic Products (CNBG) (China) Key News & Latest Developments
9.7 CSL Behring (US/Germany)
9.7.1 CSL Behring (US/Germany) Company Summary
9.7.2 CSL Behring (US/Germany) Business Overview
9.7.3 CSL Behring (US/Germany) Antiviral Immunoglobulin Major Product Offerings
9.7.4 CSL Behring (US/Germany) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.7.5 CSL Behring (US/Germany) Key News & Latest Developments
9.8 Emergent BioSolutions (US)
9.8.1 Emergent BioSolutions (US) Company Summary
9.8.2 Emergent BioSolutions (US) Business Overview
9.8.3 Emergent BioSolutions (US) Antiviral Immunoglobulin Major Product Offerings
9.8.4 Emergent BioSolutions (US) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.8.5 Emergent BioSolutions (US) Key News & Latest Developments
9.9 GC Pharma (S. Korea)
9.9.1 GC Pharma (S. Korea) Company Summary
9.9.2 GC Pharma (S. Korea) Business Overview
9.9.3 GC Pharma (S. Korea) Antiviral Immunoglobulin Major Product Offerings
9.9.4 GC Pharma (S. Korea) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.9.5 GC Pharma (S. Korea) Key News & Latest Developments
9.10 Grifols (Spain)
9.10.1 Grifols (Spain) Company Summary
9.10.2 Grifols (Spain) Business Overview
9.10.3 Grifols (Spain) Antiviral Immunoglobulin Major Product Offerings
9.10.4 Grifols (Spain) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.10.5 Grifols (Spain) Key News & Latest Developments
9.11 Hualan Biological (China)
9.11.1 Hualan Biological (China) Company Summary
9.11.2 Hualan Biological (China) Business Overview
9.11.3 Hualan Biological (China) Antiviral Immunoglobulin Major Product Offerings
9.11.4 Hualan Biological (China) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.11.5 Hualan Biological (China) Key News & Latest Developments
9.12 Intas Pharmaceuticals (India)
9.12.1 Intas Pharmaceuticals (India) Company Summary
9.12.2 Intas Pharmaceuticals (India) Business Overview
9.12.3 Intas Pharmaceuticals (India) Antiviral Immunoglobulin Major Product Offerings
9.12.4 Intas Pharmaceuticals (India) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.12.5 Intas Pharmaceuticals (India) Key News & Latest Developments
9.13 Kamada (Israel)
9.13.1 Kamada (Israel) Company Summary
9.13.2 Kamada (Israel) Business Overview
9.13.3 Kamada (Israel) Antiviral Immunoglobulin Major Product Offerings
9.13.4 Kamada (Israel) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.13.5 Kamada (Israel) Key News & Latest Developments
9.14 Kedrion (Italy)
9.14.1 Kedrion (Italy) Company Summary
9.14.2 Kedrion (Italy) Business Overview
9.14.3 Kedrion (Italy) Antiviral Immunoglobulin Major Product Offerings
9.14.4 Kedrion (Italy) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.14.5 Kedrion (Italy) Key News & Latest Developments
9.15 LFB Group (France)
9.15.1 LFB Group (France) Company Summary
9.15.2 LFB Group (France) Business Overview
9.15.3 LFB Group (France) Antiviral Immunoglobulin Major Product Offerings
9.15.4 LFB Group (France) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.15.5 LFB Group (France) Key News & Latest Developments
9.16 Octapharma (Switzerland)
9.16.1 Octapharma (Switzerland) Company Summary
9.16.2 Octapharma (Switzerland) Business Overview
9.16.3 Octapharma (Switzerland) Antiviral Immunoglobulin Major Product Offerings
9.16.4 Octapharma (Switzerland) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.16.5 Octapharma (Switzerland) Key News & Latest Developments
9.17 Regeneron (US)
9.17.1 Regeneron (US) Company Summary
9.17.2 Regeneron (US) Business Overview
9.17.3 Regeneron (US) Antiviral Immunoglobulin Major Product Offerings
9.17.4 Regeneron (US) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.17.5 Regeneron (US) Key News & Latest Developments
9.18 Roche (Switzerland)
9.18.1 Roche (Switzerland) Company Summary
9.18.2 Roche (Switzerland) Business Overview
9.18.3 Roche (Switzerland) Antiviral Immunoglobulin Major Product Offerings
9.18.4 Roche (Switzerland) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.18.5 Roche (Switzerland) Key News & Latest Developments
9.19 Sanofi (France)
9.19.1 Sanofi (France) Company Summary
9.19.2 Sanofi (France) Business Overview
9.19.3 Sanofi (France) Antiviral Immunoglobulin Major Product Offerings
9.19.4 Sanofi (France) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.19.5 Sanofi (France) Key News & Latest Developments
9.20 Shanghai RAAS (China)
9.20.1 Shanghai RAAS (China) Company Summary
9.20.2 Shanghai RAAS (China) Business Overview
9.20.3 Shanghai RAAS (China) Antiviral Immunoglobulin Major Product Offerings
9.20.4 Shanghai RAAS (China) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.20.5 Shanghai RAAS (China) Key News & Latest Developments
9.21 Shuanglin Bio (China)
9.21.1 Shuanglin Bio (China) Company Summary
9.21.2 Shuanglin Bio (China) Business Overview
9.21.3 Shuanglin Bio (China) Antiviral Immunoglobulin Major Product Offerings
9.21.4 Shuanglin Bio (China) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.21.5 Shuanglin Bio (China) Key News & Latest Developments
9.22 SK Plasma (S. Korea)
9.22.1 SK Plasma (S. Korea) Company Summary
9.22.2 SK Plasma (S. Korea) Business Overview
9.22.3 SK Plasma (S. Korea) Antiviral Immunoglobulin Major Product Offerings
9.22.4 SK Plasma (S. Korea) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.22.5 SK Plasma (S. Korea) Key News & Latest Developments
9.23 Takeda Pharmaceutical (Japan)
9.23.1 Takeda Pharmaceutical (Japan) Company Summary
9.23.2 Takeda Pharmaceutical (Japan) Business Overview
9.23.3 Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Major Product Offerings
9.23.4 Takeda Pharmaceutical (Japan) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.23.5 Takeda Pharmaceutical (Japan) Key News & Latest Developments
9.24 Tiantan Bio (China)
9.24.1 Tiantan Bio (China) Company Summary
9.24.2 Tiantan Bio (China) Business Overview
9.24.3 Tiantan Bio (China) Antiviral Immunoglobulin Major Product Offerings
9.24.4 Tiantan Bio (China) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.24.5 Tiantan Bio (China) Key News & Latest Developments
9.25 Weiguang Biological (China)
9.25.1 Weiguang Biological (China) Company Summary
9.25.2 Weiguang Biological (China) Business Overview
9.25.3 Weiguang Biological (China) Antiviral Immunoglobulin Major Product Offerings
9.25.4 Weiguang Biological (China) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.25.5 Weiguang Biological (China) Key News & Latest Developments
9.26 Yuanda Shuyang (China)
9.26.1 Yuanda Shuyang (China) Company Summary
9.26.2 Yuanda Shuyang (China) Business Overview
9.26.3 Yuanda Shuyang (China) Antiviral Immunoglobulin Major Product Offerings
9.26.4 Yuanda Shuyang (China) Antiviral Immunoglobulin Sales and Revenue in Global (2021-2026)
9.26.5 Yuanda Shuyang (China) Key News & Latest Developments
10 Global Antiviral Immunoglobulin Production Capacity, Analysis
10.1 Global Antiviral Immunoglobulin Production Capacity, 2021-2034
10.2 Antiviral Immunoglobulin Production Capacity of Key Manufacturers in Global Market
10.3 Global Antiviral Immunoglobulin Production by Region
11 Key Market Trends, Opportunity, Drivers and Restraints
11.1 Market Opportunities & Trends
11.2 Market Drivers
11.3 Market Restraints
12 Antiviral Immunoglobulin Supply Chain Analysis
12.1 Antiviral Immunoglobulin Industry Value Chain
12.2 Antiviral Immunoglobulin Upstream Market
12.3 Antiviral Immunoglobulin Downstream and Clients
12.4 Marketing Channels Analysis
12.4.1 Marketing Channels
12.4.2 Antiviral Immunoglobulin Distributors and Sales Agents in Global
13 Conclusion
14 Appendix
14.1 Note
14.2 Examples of Clients
14.3 Disclaimer
